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Summary.-An assay system is described in which effector cells added along with
suitable target cells inhibit, in a quantitative fashion, the subsequent uptake of
3H-thymidine bythose target cells. Effector cells active inthis assay, using embryonic
fibroblast cells as targets, develop spontaneously in cultures of mouse lymphoid cells,
but are apparently different from those described earlier by investigators of activity
in cytotoxic assays. Further evidence is presented to show the development of spleen-
derived effector cells with cytostatic activity (for embryonic fibroblast target cells) in
mice during the course of normal pregnancy, or growth of spontaneously appearing
mammary adenocarcinomas. Indeed, such effector cells can also be found within the
growing solid mass itself. Different populations of tumour cells isolated from a solid
tumour apparently differ in their susceptibility to growth inhibition by tumour-
bearer-derived cytostatic effector cells, a phenomenon which may be related to
metastatic spread of tumour cells.
WE HAVE REPORTED several studies in-
vestigating the ability of embryo-immun-
izedlymphocyte populations to show cyto-
toxicity to syngeneic embryonic fibroblast
cells in vitro (Gorczynski, 1976a,b,c; 1978)
and have recently shown a correlation
between this cytotoxicity and the ability
ofthose cells to modify the growth charac-
teristics of an s.c. tumour implant in vivo
(Gorczynski & MacRae, unpublished). In
contrast to these findings are those in
which no tumour growth inhibition (or
enhanced tumour growth) was observed
using embryo-immune lymphoid cellpopu-
lations (Pearson & Freeman, 1968; Ting,
1968; Basombrio & Prehn, 1972). Never-
theless, a previous analysis ofthe develop-
ment of lung metastases from rat hepat-
omas has suggested a role for embryo-
immune cells in retarding the develop-
ment of such secondary growth (Baldwin
et al., 1974).
When a preliminary comparison was
made between spleen cells able to affect
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the growth oftumour nodules in the lungs
of syngeneic mice (after i.v. inoculation of
tumour cells) and those causing decreased
growth of an s.c. implant of cells or cyto-
toxicity in vitro, little correlation was seen
between cytotoxicity and protection after
i.v. transfer (manuscript in preparation).
In terms of clinical disease, understanding
control of distant tumour growth (meta-
static spread) is a greater problem than
controlling local growth. Moreover, given
evidence that the state of macrophage
activation (Hibbs, 1973) and macrophage
infiltration of tumours (Eccles & Alex-
ander, 1974) is correlated with metastasis,
the discrepancy above may not be alto-
gether unexpected, for we have presen-
ted evidence that at least in some cell
populations the cytotoxic effector cells
are predominantly lymphoid in origin
(Gorczynski, 1976b). Thus, we have sought
to develop alternative (to cytotoxicity)
assays which correlate better with the
ability of cell populations to regulate theR. M. GORCZYNSKI AND S. MACRAE
growth oftumour cells after systemic (i.v.)
inoculation, rather than s.c. inoculation.
The data presented below indicate that an
assay system based on the ability of
lymphoid cells to inhibit the growth of
syngeneic embryo fibroblasts (as assessed
by radioactive labelling after a 48h
culture) rather than to cause cytolysis of
pre-labelled (3H-proline) embryo fibro-
blasts, detects a unique effector-cell popu-
lation. This effector cell(s) is generated
during natural sensitization to embryonic
antigens (in pregnancy) or to tumour anti-
gens which cross-react with embryonic
antigens (during tumour growth). Similar
effector cells can also be found in cell
populations prepared from the solid
tumour istelf, and their presence therein
may be related to the facility with which
tumour cells give rise to nodules in
recipients of i.v. (rather than s.c.) tumour
material.
MATERIALS AND METHODS
Mice.-C3H/HeJ C57BL1O SgN (subse-
quently designated BlO) and B1O.BR mice
were obtained from the Jackson Labora-
tories, Bar Harbor, Maine. All mice were kept
5 to a cage and given food and water ad
libitum.
Timed pregnancies were induced by leaving
male and female mice together for 16-20 h.
Pregnant mice (vaginal-plug technique) were
separated on the following morning. Birth
occurred at 20 to 21 days of gestation.
Tumours. - Retired breeder mice from
Jackson Laboratories were inspected twice
weekly for the appearance of spontaneous
tumours. When such a tumour (mammary
adenocarcinoma: Department of Histology/
Pathology, Princess Margaret Hospital) was
- 1.5 cm3 in volume the animals were killed
by cervical dislocation, the tumour removed
aseptically in phosphate-buffered saline
(PBS) and an enzyme digest made of the
solid mass as described earlier (Gorczynski,
1978; Russell et al., 1976). The yield was
routinely of the order 5-9 x 107 viable cells.
Tumour cells were adoptively transferred
s.C. (106 cells in 0-15 ml PBS) into normal
female C3H mice, as described in the text.
When tumours were resected the operation
was performed under ether anaesthesia.
Tumour volume was measured as described
elsewhere (Gorczynski, 1978; Attia et al.,
1965).
Preparation of lymphoid cells, embryo fibro-
blasts, embryo cell extracts, irradiation, velocity
sedimentation and cell culture techniques.-
These have all been described in detail else-
where (Gorczynski, 1978).
Antisera and antisera treatment.-Rabbit
anti-mouse-brain theta-associated serum
(anti-Br 0) and rabbit anti-mouse-B-lympho-
cyte sera (anti-B) were prepared and tested
as reported earlier (Gorczynski, 1976d). All
cells were tested with antibody for 60 min at
4°C (cells at 107/ml), washed and incubated
in mouse-spleen-absorbed rabbit complement
(diluted 1/10 in cxFi0) for 45 min at 37°C.
Microcytotoxicity and cytostasis assays.-
The cytotoxicity assay has been described in
detail elsewhere (Gorczynski, 1978). In brief,
106 embryo fibroblasts, pre-labelled for 18 h
with 150 ItCi of 3H-proline (630 ,Ci/mmol;
Radiochemicals Centre, Amersham) in pro-
line-free ox-MEM (with 10% foetal calf serum,
otFlo) were aliquoted and dispensed in 100/-tl
amounts to each well of a 96-well Linbro
microtest plate (Linbro Chemical Company,
New Haven, Conn.)-2 x 103 cells were added
per well. After 3 h (to allow target cells to
adhere) effector cells were added at different
concentrations in a final total volume of
200 pl aFlo. At 48 h of incubation, 100Mul
samples of each supernatant were removed,
dispersed in 5 ml Aquasol (New England
Nuclear, Boston, Mass.) and counted in a
well-type scintillation counter. Control wells
contained medium only (spontaneous ct/min
released) or water (maximum releasable
ct/min). Percentspecific cytotoxicity was then
calculated as:
ct/min experimental-
100 x_e_ _ ct/min spontaneous ct/min H20 -ct/min spontaneous
The cytostasis assay used was but a minor
modification of this cytotoxicity assay.
Unlabelled embryo fibroblast cells (2 x 103)
were dispensed in 100 ,u into each well of 96-
well Linbro plates. After 3 h effector cells
were added at different concentrations in a
total volume of200 PI oxFjo. At 48 h the plates
were removed from the incubator, the wells
washed x 3 with sterile warm PBS, and
200 ,ul of 3H-thymidine (dT) (0 5 ,uCi per
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well) in aF1o was added to each well. The
plates were then returned to the incubator.
After 8 h all wells were washed thoroughly
with warm oaFlo and allowed to dry at room
temperature. N NaOH (0.15 ml) was added to
each well, and after 2 h the contents of each
well was transferred to scintillation vials. The
wells were washed out with 0415ml N HC1
transferred to the corresponding vials. To
each was now added 5 ml Aquasol, and the
ct/min in each vial determined as before.
Per cent specific cytostasis was calculated as:
ct/min medium -ct/min experimental
ct/min medium
Clearly this is an accurate measure of cyto-
stasis only in the absence ofcytotoxicity from
the population under test (see also the text).
Statistical analysis.-Statistical comparison
of experimentally determined parameters for
different groups of animals (or cell popula-
tions derived from them) were made by a non-
parametric (Mann-Whitney) test. Correlation
coefficients for analysis of the activities of a
series of cell populations in two assays were
also calculated (Freund, 1962).
RESULTS
Quantitation of cytostatic assay using cells
from cultured spleen populations, and lack
of correlation between cytotoxicity and cyto-
static assays
Early studies have documented that
cultured spleen cells spontaneously de-
velop cytolytic activity which can be
shown to be directed at least in part
against syngeneic embryo-associated anti-
gens (Gorezynski, 1976a). In order to
investigate the relationship between cyto-
toxic and cytostatic effector cells, and
whether the latter cells even appeared
concomitantly with the former, we have
performed the two types of assay (de-
scribed in Materials and Methods) on a
pool of spleen cells harvested from 5-day
cultures of 3 x 108 normal C3H female
cells (prepared initially from 4 donors).
Fresh spleen cells were also prepared at
the time the cultured cells were harvested,
from a pool of 3 donors.
Multiple concentrations of the unfrac-
tionated cell populations and subpopula-
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FIG. 1. Velocity sedimentation analysis of
cytotoxic and cytostatic effector cells
pooled from 5-day cultures of normal C3H
spleen cells. 5 x 107 cells were sedimented
for 4 h at 4°C and the data shown represent
the activity in 055% of the recovered cells
per fraction for 2 x 103 target cells (equiva-
lent to a total unfractionated effector:
target ratio of 120:1). Since this is at ornear
the plateau of cytotoxic activity for un-
fractionated cells, this analysis may under-
estimate the discontinuities in the activity
ofdifferent fractions.
tions of cells isolated after sedimentation
of 5 x 107 of the spleen-cell preparations
for 4 h at 4°C, were assayed here and in all
subsequent experiments. Cells differing in
sedimentation velocity by 1 mm/h were
collected. All cell samples tested were
assayed in triplicate in both cytotoxicity
and cytostasis assays. Preliminary data
with unfractionated cells established that
both assays gave linear cytotoxicity
(18 + 1.9% at 120:1 effector:target) or
cytostasis (80 + 7.40/ at 80:1) in the range
3:1 to 80:1 effector:target cell using
2 x 103 target cells/well and expressing
cytotoxicity/cytostasis vs log effector:
target. Data shown in Fig. 1, while repre-
sentative of only one effector:target ratio,
equivalent to an unfractionated effector:
target ratio of 120:1, show that while
cytotoxic cells necessarily show activity in
the cytostasis test, there is nevertheless
good evidence that the latter assay de-
tects a unique population of cells not
observed by cytotoxicity assays (e.g. the
cytostasis was seen with cells of sedi-
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mentation velocity 2-5-4 mm/h and 6-5-8
mm/h).
Specificity of effector cells in cytostasis and
cytotoxicity for syngeneic or allogeneic tar-
gets, and inhibition of reactivity by soluble
extracts of whole embryos
Previous studies have shown that the
specificity of the spontaneously appear-
ing cytotoxic effector cells (from spleen
lymphocytes cultured for 4-5 days in
oaFio) is at least partially explained in
terms of reactivity to self embryonic-type
antigens, though cross-reactivity with
embryo-associated determinants of other
genetically defined composition was often
observed (Gorezynski, 1978). In order to
investigate the specificity of cells with
cytostatic activity which appear in these
same cultures we have compared: (i) the
activity of cultured C57BL 10 or C3H
spleen lymphocytes for inhibition of
growth of C57BL 10 and C3H embryo
fibroblasts, and (ii) the effect of addition
of soluble extracts prepared from whole
embryos on the cytostatic capacity of
cultured C3H cells for C3H embryo fibro-
blasts.
Spleen cells of C57BL 10 or C3H/HeJ
female mice were cultured for 5 days at a
concentration of 2 x 106 cells/ml in oFlo;
2 x 108 cells were initially cultured. The
recovered cells (4-5 x 107 viable cells in
both cases) were then sedimented for 4 h
at 4°C. Cell populations differing in
sedimentation velocity by 1P5 mm/h were
collected, centrifuged and resuspended in
oxF1o. 1.0%, 0.3% and 0.1% of the cells in
each fraction were then added to wells of
Linbro microtest plates already containing
2 x 103 embryo fibroblasts of either C3H
or C57LB 10 origin After 48h incubation
all wells were pulsed with [3H]-dT and
cytostasis measured as described before.
In addition, for the cultured C3H lympho-
cytes only, a repeat series ofassay cultures
was set up containing identical numbers of
effector cells and embryo fibroblasts, but
with all wells receiving 20 ,uI (representing
15 vg protein) of a soluble antigen extract
of 13-day C3H whole embryos, in an
attempt to "block" cytostasis directed
towards embryonic antigen components
on the target C3H embryo fibroblasts.
This extract has previously been shown to
have no effect, up to a concentration of
250 ug/ml, on the sensitization or effector
stages of alloreactive responses (e.g. C3H
anti-C57BL 10 cytotoxicity, unpublished).
Typical dataforthis experiment are shown
in Fig. 3 (pooled data from 4 independent
experiments are shown in Table I).
There are several points of interest in
this Figure. Firstly, the data of panels (a)
and (b) suggest that a comparatively high
degree of strain specificity exists for cyto-
TABLE I.-Target specificity of cytotoxic effector cells derived from cultured mouse
splenocytes
% specific cytostasist for embryo fibroblasts of
C--
Origin ofeffector cells*
( ---- - '
Peak
sedimen-
tation
Strain velocity
C57BL10 2-4-5 mm/h
6-5-10mm/h
C3H/HeJ 2-4-5 mm/h
6-5-10 mm/h
C57BL10
C3H C3H
No whole- adult
antigen embryo spleen
extract extract cells
24+4 18+4 21+4
29+5 28+5 27+5
13+3 6+2 8+1
31+5 29+5 29+4
C3H/HeJ
C3H C3H
No whole- adult
antigen embryo spleen
extract extract cells
5+ 1
41+5
11+3
47+6
10+2
43 + 4
36+5
49+7
8+3
43 + 5
28+4
48+7
* Obtained by velocity sedimentation of spleen cells harvested from 5-day cultures of cell preparations
using 5 mice of each of the strain shown (see also Legend to Fig. 2).
t % specific cytostasis (for 2 x 103 targets) at 48 h1 using an effector:target ratio of50:1 (small cells) or 10:1
(large cells). All assays were performed in triplicate with a range ofeffectors :targets such that the cytostasis
could be assessed in a quantitative manner. The values shown represent arithmetic means (± s.e.) summed
over 4 independent experiments performed ovei a period of 14 weeks (using the same frozen batch of target
cells).
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stasis caused by the small effector cells
(sedimentation velocity 2-5 mm/h); P
values for cytostasis of C57BLlO lympho-
cytes on C57BLl0 vs C3H targets ranged
from < 0 05- < 0-01, and for C3H lympho-
cytes on C3H vs C57BLIO targets from
<0 05- <001 (panel (b)). In contrast,
activity in the faster-sedimenting pool of
effector cells (6-11 mm/h) was roughly the
same for any effector source, irrespective
of the strain used to derive the embryo
fibroblasts (no significant differences in
panel (a); P values 0410 for panel (b)).
Using the reciprocal specificity test used
here (both effectors tested on both tar-
gets) we were able to overcome problems
of apparently "false" specificity intro-
duced by a difference in the ease ofcausing
cytostasis with the two targets (e.g. com-
pare only *- -0 in panels (a) and (b)
which suggest a significant degree of
specificity in both slow and fast-sediment-
ing effector cells). When soluble embryo
extracts were used to inhibit the cyto-
stasis (panel (c)) further light was thrown
on the specificity of the reactions.
Good inhibition (0-* compared with
a ... 0) of reactivity was seen using
the slow-sedimenting effector-cell pool (P
005-<001 for cells with sedimentation
velocity from 2 mm/h-6 mm/h) and rather
poorer inhibition with the faster-sediment-
ing pool (sedimentation velocity > 8 mm/
h; P < 0.05). Statistical comparison of
the difference in inhibition by small or
large cells gave P < 0 01. These data
suggest that under our conditions, cyto-
stasis can be mediated by 2 populations
found to appear spontaneously in cultures
of spleen lymphocytes, one of which has
demonstrable embryo-antigen specificity
(and probably self-embryo antigen speci-
ficity; see also the specificity of spon-
taneously appearing cytotoxic effector
cells (Gorczynski, 1976a)) the other lack-
ing embryo antigen and strain specificity.
These conclusions are supported by the
data of Table I (indicating a composite of
4 experiments of the type shown in Fig. 3)
which also establish that no inhibition of
cytostasis was seen with equivalent con-
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FIG. 2. Strain and antigen specificity of
cytostasis developing in cultures of murine
spleen lymphocytes; see text for further
(letails. All points represent arithmetic
means of triplicate cultures (s.e. < 15%).
The target cells used in the assays were
embryo fibroblasts of 14-day embryos of
C3H (b) or C57BL.10 origin; a soluble
antigen extract, of the C3H embryos (c) was
also prepaied as described in Materials and
Methods, and included in the assay cultures
at a concentration of 50 ,ug/ml. Effector
cells were assayed at varying concentrations
(1% 0.300/ and 0-1% of the fractions
recovered after sedimenting 4 x 107 cells)
the cytostasis (for 2 x 103 targets) shown
being that represented by 0-3o of the cells/
fraction (equivalent to a total unfraction-
ated effectoi:target ratio of 60:1).
(
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centrations of extracts from adult spleen
cells (or adult liver cells, unpublished).
Analysis of effector cells for cytostatic
activity
Since the data above showed a differ-
ence in the specificity of effector cells in
the 2 pools indicated in Figs 2 and 3, we
asked whether these cells differed also in
their origin (lymphocytic, granulocytic
etc.). Accordingly, spleen cells derived
0
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FIG. 3.-Analysis of cytostatic effector-cell
populations during pregnancy and different
phases of tumour growth; for more details
see text. Groups ofmice received a plimary
transplant of adeno31 tumour cells (106
s.c.) at 20-day intervals and the resultant
tumours were surgically removed at appro-
priate times. All animals were used on the
same day (panel a). In addition, at a set
point of this same time scale, female mice
were mated at 10-day intervals (panel b).
Spleen cells in all groups of animals were
sedimented for 3 h at 40°C, and cells of the
different fractions tested at varying concen-
trations for their cytostasis with 2 x 103
embryo fibroblast targets. The data shown
represent cytostasis with 0.3% of the cells/
fraction (equivalent to total unfractionated
effector:target ratio of 150:1; which was on
the linear portion of the dose-response
curve foreach effector population studied in
this experiment).
from 5-day cultures ofC3H female lymph-
oid cells (from an initial culture of 3 x 108
cells from 4 animals) were sedimented as
before and the cells with sedimentation
velocity 2-4-5 mm/h and 6-5-9-0 mm/h
collected. Five x 106 cells from each pool
were subjected to treatment with anti-
Br 0 serum and complement, anti-B cell
serum and complement, or to adherence
depletion (2 x 60 min at 37°C in ocFlo on
35 mm glass Petri dishes; thenon-adherent
cells were used subsequently (Gorczynski,
1976d)). Aliquots of the untreated or
treated populations were then added at
varying cell concentrations to 2 x 103 C3H
embryo fibroblasts, and assayed in a 48h
cytostasis test as before. Data from 3
experiments of this nature are shown in
Table II.
TABLE II.-Properties of effector cells in-
volved in cytostasis assays
Treatmentt
Source of of % specific cytostasist
effector* effector ,r-
cells population Expt 1 Expt 2 Expt 3
2-4-5mm/h None 27+3 26+2 28+4
Anti-Br
O+c1 8+2 7+ 1 9+2
Anti-B+c1 29+3 30+5 26+2
Adherence
depletion 11 + 2 10+ 2 14+ 3
6-5-9mm/h None 38+5 33+4 35+3
Anti-Br
O+c1 34+4 36+4 30+2
Anti-B+cl 33+4 35+4 31+2
Adherence
depletion 12 + 3 10 + 2 3 + 2
* As for * in Table I.
t Preparation of antisera and treatment schedules
are noted in Materials and Methods and the text.
t Arithmetic mean (±s.e.) of triplicate deter-
minants of cytostasis at 48 h for 2 x 103 C3H
embryo fibroblast target cells, using an effector:
target ratio (after treatment) of 50:1 (small cells)
or 10:1 (large cells).
It is clear from these data that not only
the specificity (and cell size) ofthe effector
populations described earlier is different,
but also their biological origin. A consider-
able proportion of the activity derived
from the slow-sedimenting pool of cells is
apparently due to T cells (either adherent,
or needing an auxiliary adherent cell for
manifestation of their activity) whereas
a)
0
° lX2 _2/; IiResected 20days
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activity derived from the faster-sediment-
ing pool of cells is apparently due to a
non-B, non-T, glass-adherent cell. Once
again these data are in contrast to the
nature of cytotoxic effector cells derived
from such cultured populations (non-T
cell, activity diminished by anti-B sera
(Gorczynski, 1976b).
Induction of cells with cyto8tatic capacity
during pregnancy and tumiour growth
Given the evidence above that at least
a portion of the cells active in the cyto-
stasis assay were demonstrating embryo-
antigen specificity, and our earlier experi-
ence with induction of embryo-antigen-
specific cytotoxic cells during pregnancy
(and tumour growth) (Gorczynski, 1978;
Gorczynski & MacRae, unpublished) it
was of interest to us to explore whether
this natural exposure to embryonic anti-
gens (or tumour antigens cross-reactive
with these) also enhanced cytostasis.
Groups of 4 C3H female mice were
s.c. implanted at 20-day intervals in 0415
ml PBS with 106 cells prepared from a
spontaneously appearing adenocarcinoma
(adeno31). Excess tumour cells from the
freshly killed original donor were frozen in
liquid N2. When the tumour volume was
1.5 cm3 (Day 15-20 in all groups) the
tumour was removed under ether anaes-
thesia. At Day 80 the final group of
animals was inoculated to serve as tumour
bearers on Day 100. At Day 60, on this
time scale, groups of 6 C3H female mice
were mated overnight with 3 normal C3H
males (2 females/cage). Pregnant mice
(vaginal plug technique) were marked and
separated. This was repeated at 10-day
intervals up to Day 90. Retired breeder
mice used in these experiments were 10-
month-old C3H females which had had at
least 4 litters, the last of which was born
at least 3 months earlier. All groups con-
tained a minimum of 3 mice. The strategy
for design of this experiment is indicated
schematically below.
At Day 100 equivalent spleen prepara-
tions were pooled from all experimental
groups (5 tumour groups; 4 groups at
various stages of pregnancy; 1 group of
retired breeder mice) and from a group of
5 normal female C3H mice (6 months old).
108 cells of all groups were sedimented for
3 h at 4°C and fractions differing in sedi-
mentation velocity by 1-5 mm/h collected.
1%, 0.300 and 0.1% of the cells in each
fraction were added in triplicate to wells
already containing 2 x 103 embryo fibro-
blasts and a cytostasis assay performed as
described above. Data for this experiment,
showing the cytostasis observed with 0.3%
of the cells per fraction (the linear portion
of the dose-response curve for these
fractions) are shown in panels (a) and (b)
ofFig. 3.
The data in the lower panel, showing
cytostasis at various times of gestation,
post-partum, or in retired breeder females,
indicate that the first observable change
in activity at the times tested is apparently
an enhanced cytostasis of slow-sediment-
ing cells (10-day gestation; P relative to
cytostasis with equivalent control cells
< 0.05). At 20 days of gestation and at 10
days post-partum, an increase in cyto-
stasis in slow-sedimenting and fast-sedi-
menting cells is seen (P relative to control
< 0-01 in each case. A significant increase
in cytostasis in the slow-sedimenting cell
population has occurred over the activity
at 10 days of gestation (P < 0.005)). Later
this increased activity in large cells may
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diminish (e.g. 20 days post-partum); in
retired breeder animals the most signifi-
cant difference from normal controls is
again associated with enhanced activity
in the small-cell pool (P<0-01; P<0-05
for the difference in cytostasis in large cells
relative to 10-day post-partum cells).
Similar changes in cytostatic activity
occur in slow- and fast-sedimenting cells
after s.c. tumour implantation (panel a).
In tumour bearers increased cytostatic
activity over normal cells exists only in
the large-cell region (P< 0.05 relative to
normal cells). This activity is considerably
enhanced after tumour resection (e.g. at 20
days after resection significant cytostasis
is seen in both small and large cells;
P< 0-01 in each case). One interesting
difference between this group of animals
and those in panel (b) however is seen
when longer times after resection are
studied. The activity in large cells clearly
declines towards normal levels (60-80-day
resected animals) and so does activity in
the small-cell region of the gradient on
Day 80, for cytostasis in small cells rela-
tive to control (P< 0-10). This loss of
maintenance of/or activity in small cells
(lymphocytes?) may be associated wvith
tumour recurrence (manuscript in prep-
aration). Equivalent data to those shown
in Fig. 3 have been obtained with other
spontaneous adenocarcinomas(adenols,2s).
Induction of enhanced cytostasis in vitro by
sensitization to embryonic antigens
We have reported elsewhere that the
spontaneous cytotoxicity (for targets bear-
ing embryonic antigens) developing in
cultures of immune spleen lymphocytes is
not greatly enhanced by deliberate ex-
posure of those cells during culture to
additional embryonic antigen determin-
ants (Gorczynski, 1976a). In addition
(above) we have shown that spontaneous
cytostasis (over that shown by normal
spleen cells; compare Figs 1 and 3) also
develops from such cultures, and that a
significant amount of this reactivity could
be attributed to recognition of embryonic
antigens (Fig. 2). In order to assess
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FIG. 4.-Specifically enhanced cytostasis after
sensitization toirradiatedsyngeneic embryo
cells (from 14-day-old C3H mice; C14) or
to histoincompatible spleen cells (BLO oi
BIO.BR). 2 x 108 spleen cells (from a pool of
8 normal C3H females) were cultured for 5
daysunderthe conditions indicated. Follow-
ing this, 5 x 107 cells ofeach pool or afreshly
prepared spleen cell pool ( x - - x ) were
sedimented for 3 h at 4°C and varying con-
centrations of each fraction tested with
2 x 103 embryo fibroblast targets. The latter
were labelled at 48 h with [3H]-dT (panels
a, b) or pre-labelled (panel c, cytotoxicity
assay) with 3H-proline as described in the
text. Data shown represent the activity
from 0.3% of the cells/fraction (equivalent
to a total unfractionated effector :target
ratio of 75:1). All values are arithmetic
means (s.e. 15%) of 3 cultures.
whether deliberate sensitization appreci-
ably enhanced cytostatic activity we have
cultured C3H spleen lymphocytes either
alone, or in the presence of irradiated
(15 Gy) syngeneic embryo cells (prepared
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from 14-day embryos-C14). 104 embryo
cells were added per 2-5 x 106 spleen cells
in 2ml oFlo. Control cultures in which
spleen cells were sensitized against major
(irradiated C57BL10 spleen cells) or minor
(irradiated B10BR spleen cells) histo-
compatibility antigens were included to
ensure that any enhanced cytostasis was
not merely a reflection of cellular activa-
tion and proliferation per se. Five days
after initiation of cultures, 5 x 107 cells of
each spleen cell pool were sedimented, and
the different fractions tested as before at
various cell concentrations for cytostasis
to 2 x 103 C3H embryo fibroblasts, or for
cytotoxicity and cytostasis to C57BL10
embryo fibroblasts (also prepared from
14-day-old embryos). Data for one of two
experiments of this type are shown in
Fig. 4.
It is evident that sensitization against
syngeneic C3H embryo cells does increase
anti-C3H embryo fibroblast cytostatic
activity in both large- and small-cell
effector populations (panel a) in contrast
to a failure to increase cytotoxic effector
cells. P values for enhancement cyto-
stasis relaVive to that seen with unsensi-
tized cells (slow and fast sedimenting) are
< 0 05 in each case. No such increase over
control cultured cells is seen if assayed
upon BlO embryo fibroblasts (panel b).
Stimulation with allogeneic cells (B10) did
not enhance cytostasis for C3H embryo
fibroblasts, though it did cause significant
enhancement of cytostasis assayed on
C57BL1O embryo fibroblasts (for cyto-
stasis in small and large cells vs unsensi-
tized cells P< 0.05-panel b) and pro-
duced pronounced cytotoxicity for the
latter (panel c). Stimulation with minor
MHC antigens (B1OBR cells) apparently
decreased the cytostasis seen on C3H cells
(panel a), no significant cytostasis relative
to fresh uncultured spleen cells) while
increasing cytostasis seen with BlO fibro-
blasts (small and large cells vs unsensitized
cells P < 0.05). Quite clearly the cellular
events underlying development of cyto-
static and cytotoxic activity are very
complex, but it is also apparent that (i)
cytostasis for autologous embryo-fibro-
blast cells can be enhanced by deliberate
sensitization with autologous embryo cells,
and (ii) that mere stimulation and activa-
tion of T lymphocytes is not sufficient for
development of enhanced cytostasis in
culture. Indeed, in this Figure allo-
sensitization (C3H vs BlO) enhanced cyto-
stasis and cytotoxicity in the same pool
of cells sedimenting in the range 5-9
mm/h, unlike the biphasic distribution of
enhanced cytostasis (for C3H targets)
seen after embryo sensitization (panel a).
Evidence for cytostatic effector cells within
solid tumours and for a difference in the
susceptibility of tumour cells to their action
The data of Fig. 3 lead us to infer that
the cytostatic effector cells are in some
way related to tumour growth in the
autologous host. We have already shown
that solid tumours can be infiltrated with
cells which have demonstrable cytotoxic
activities assayed on syngeneic embryo
fibroblasts in vitro (Gorezynski & MacRae,
unpublished). In order to assess whether
cytostatic cells also exist within tumours,
and if so whether they can be shown to be
effective in vitro against the autologous
tumour cells, we have preformed the
following experiment.
A primary spontaneous tumour
(adeno32) was disaggregated and 8 x 107
cells fractionated for 150 min at 40C. Cell
differing in sedimentation velocity by
3 mm/h were collected, centrifuged and
resuspended in ouFlo. Aliquots of each cell
fractionwere testedin triplicate atvarying
dilutions for their sytostatic effect on
embryo fibroblasts prepared from syn-
geneic 14-day embryos (Fig. 5, upper
panel).
In addition, fractions containing cells
morphologically identified as tumour cells
(in general any fraction containing cells
with sedimentation velocity > 5*5-6-5
mm/h) were themselves used as a source
of target cells (1.0% of the fraction/well
in 96-well Linbro plates). 5% of the cells
of each of these fractions were inoculated
s.c. in 041 ml into adult normal C3H
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FIG. 5. Cytostasis within solid tumours,
and effect on autologous tumour cells;
see text for more details. 8 x 107 cells from
a spontaneously appearing adenocarcinoma
(adeno32) were fractionated for 150 min at
4°C. Aliquots of each fraction were tested
at various concentrations for cytostasis at
48 h to 2 x 103 syngeneic embryo fibroblasts.
The data in panel (a) indicate the cytostasis
seen with 0 3% of the cells/fraction (repre-
senting a total unfractionated effector:
target ratio of 120:1). In addition 1% of
the cells in each fraction were added to
each of 96-well Linbro plates. These cells
were themselves used as cytostatic assay
targets (b) for a pool of effector cells (sedi-
mentation velocity 2-4 mm/h) from the
solid tumour (x-x), normal spleen cells
(0*-0) or the tumour-bearer spleen cells
(0-0). 2 x 106 effector cells were added
per well in all cases.
female mice (4/group) to ensure ourgrowth
of tumour on primary transplant from all
fractions. Effector cells for assay of cyto-
stasis on the fractionated tumour target
cells were prepared from the small-cell
region of the tumour-cell gradient (2-4
mm/h) or from similar size (same sedi-
mentation velocity) spleen lymphocytes of
the tumour bearer or normal mice. Con-
trol cultures, measuring incorporation of
[3H]-dT in the absence of added spleen
lymphocytes, gave further evidence for
adherent proliferating cells in all tumour-
cell populations. These data are presented
in the lower panel ofFig. 5. The variation
in background [3H]-dT incorporation in
the fractions across the gradient was
< 2-5-fold (data not shown). A correlation
analysis of this background [3H]-dT in-
corporation and the tumour volume ofthe
primary transplants from each group (all
mice developed palpable tumours by 40
days from s.c. inoculation) gave a r = 0 95
(data not shown).
The first point apparent in these data,
which are representative of 3 experiments
of this type, is that only the small cells
(sedimentation velocity 2-5 mm/h) de-
rived from the tumour mass were able to
cause a significant diminution inincorpora-
tion of [3H]-dT by embryo fibroblasts
(panel a). In contrast enhanced incorpora-
tion was seen when other fractions from
the tumour mass were used in the assay;
this may be caused by the tumour cells in
the latter. More dramatic, however, were
the effects when the different tumour-cell
fractions were themselves the targets for
the cytostasis assay (panel b). In this case
marked heterogeneity in the activity of
the same effector population (either nor-
mal spleen cells, 0-0, tumour-bearer
spleen cells, 0-0, or small cytostatic
cells from within the solid tumour, x x )
was apparent, despite their having been
tested at identical effector:target ratios
for the 3 effector populations shown.
Indeed tumour-bearer spleen lympho-
cytes were singularly ineffective against
all but the slowest-sedimenting tunmour-
cell populations (peak sedimentation
velocity 5-8 mm/h). Since tumour growth
from the different fractions in vivo (s.c.
implant) and background [3H]-dT in-
corporation from the fractions in vitro
were highly correlated (see above) the
data of panel (b) may reflect a hetero-
geneity of target:effector cell interaction
within a growing tumour mass, the under-
standing of which is of importance to our
understanding of tumour metastasis.
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DISCUSSION
In an earlier paper (Gorczynski &
MacRae, unpublished) we showed that a
good correlation existed between those
cells capable of demonstrating cyto-
toxicity to syngeneic embryo fibroblasts
in vitro and those able to modify the
growth of s.c. transplants of spontaneous
adenocarcinoma cells. However, no such
correlation between cytotoxic potential
(in vitro) and the ability to modify lung
nodule growth after i.v. transfer oftumour
cells has been seen (manuscript in prep-
aration). This may not be altogether
surprising in view of the evidence that
suitably activated macrophages may be a
predominant factor in the regulation of
metastatic tumour growth (Hibbs, 1973)
whereas we have demonstrated that
lymphocyte preparations are probably
important for cytotoxic activity in vitro
(Gorczynski, 1976b). Nevertheless, we feel
a wealth of data points to the importance
of immune reactions to embryonic anti-
gens in natural anti-tumour immunity
(Gorezynski, 1976c; Gorczynski & Mac-
Rae, unpublished; Baldwin et al., 1974;
Low & Appella, 1976; Castro et al., 1973).
In an attempt to develop alternative
assays for cells sensitized against embryo-
associated determinants, we have ex-
plored an in vitro cytostasis assay which
uses labelling of targets after culture
(rather than pre-labelled targets). The
data of Tables I and II show that this
cytostatic assay can be used quanti-
tatively to compare effector-cell popula-
tions. When this is done to assess the
reactivity which appears spontaneously
in cultures in normal mouse spleen lym-
phocytes it is apparent that cytotoxic
and cytostatic activities are properties of
independent cell populations. Abundant
data exist in other tumour systems for a
difference in effector-cell type according
to the assay system used for detection of
immunity (Parmiani & Lembo, 1974;
Lamon et al., 1972; Leclerc et al., 1972;
Owen & Seeger, 1972). Indeed (see Table II
and Fig. 2) there is evidence that cyto-
stasis itself is a property of different
biological types of cells. Thus, one such
cell pool is dependent upon activity for
slow-sedimenting T cells (either adherent
or requiring accessory adherent cells for
activity) whilst another cell pool is repre-
sented by fast-sedimenting glass-adherent
non-T cells. Further, this latter cell type
apparently lacks embryonic-antigen speci-
ficity (though its induction may depend
upon immune recognition of embryo-
associated antigens; see Figs 4 and 5).
These data are reminiscent of results with
a virallv induced tumour in mice (Owen
& Seeger, 1973). Interestingly, whereas
evidence for "memory" of exposure of
embryo-associated antigens persisted in
retired breeder mice, exposure to cross-
reactive (with embryo antigens) tumour
antigens by transplantation followed by
surgical removal of tumour cells, led to a
reversible increase in cytostatic activity
(Fig. 4). This decline in cytostasis may be
related to subsequent metastatic spread
in these animals.
Recently, spontaneous cell-mediated
cytotoxicity (detectable in short-term
51Cr-release tests) has been demonstrated
in a number of species including man and
mice (Herberman & Holden, 1978; Kiess-
ling & Haller, 1978) and these effector
(natural killer, NK) cells have been impli-
cated in immune surveillance and tumour
immunity (Haller et al., 1977; Warner et
al., 1977). While it has been claimed that
human and rat NK cells are Fc-receptor
(for IgG) bearing subpopulations ofT cells
(Kay et al., 1977) Kall & Koren (1978)
have shown that the most active NK cells
in humans are non-T cells which do not
adhere to nylon-wool columns. There is no
information available to date (see review
by Kiessling & Wigzell, 1979) which would
allow us to compare the specificity of NK
cells with the cytostatic effector cells
shown here, which (see Fig. 2 and Table I)
recognize embryo-associated determinants
and can be induced in culture by exposure
to them.
In a more direct attempt to explore the
role of cytostatic effector cells in autolo-
gous tumour immunity, however, we have
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investigated the presence of such cells
within the growing tumour-cell mass
(Fig. 5). There were two types of finding.
Firstly, it was apparent that cells with
this activity did indeed exist, though their
activity did not correlate with previous
analysis of regulation of s.c. tumour
growth. Secondly, and more importantly,
different fractions of cells isolated from
within the solid tumour were found to
differ in their capacity to be inhibited
(from [3H]-dT uptake) by cytostatic
tumour-derived or, more specifically,
tumour-bearer spleen-cell-derived effector
cells. (Heterogeneity of effector cells in a
virally induced mouse tumour, as judged
by the ability of such cytotoxic effector
cells to be blocked by tumour-associated
antigens, was reported earlier by us
(Gorczynski & Knight, 1975). These find-
ings may implicate a role for a cytostatic
assay in the assessment of metastatic
capacity of various tumour cell popula-
tions, an hypothesis which is explored
further in the following manuscript.
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